0001593968-20-001630.txt : 20200713
0001593968-20-001630.hdr.sgml : 20200713
20200713164849
ACCESSION NUMBER: 0001593968-20-001630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200713
FILED AS OF DATE: 20200713
DATE AS OF CHANGE: 20200713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARRIGAN EDMUND
CENTRAL INDEX KEY: 0001177917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38958
FILM NUMBER: 201025638
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karuna Therapeutics, Inc.
CENTRAL INDEX KEY: 0001771917
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270605902
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-449-2244
MAIL ADDRESS:
STREET 1: 33 ARCH STREET
STREET 2: SUITE 3110
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2020-07-13
0001771917
Karuna Therapeutics, Inc.
KRTX
0001177917
HARRIGAN EDMUND
C/O KARUNA THERAPEUTICS, INC.
33 ARCH ST STE 3110
BOSTON
MA
02110-1424
true
false
false
false
Common Stock
2020-07-13
4
S
false
10000
93.4
D
65163
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Troy Ignelzi, Attorney-in-Fact
2020-07-13